Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study [Phase 2]
Phase 2 feasibility trial evaluated combined effects of non-statin therapies on apolipoprotein A-I up-regulation in dyslipidemia; results ha…
-
CLINICAL_TRIALS research · 2016-02-25Clinical Trial Update: Metabolic Syndrome Diagnosis and Treatment for Adults of Low Socioeconomic Status Communities [NA]
This clinical trial update describes research on diagnosing and treating metabolic syndrome in adults from low socioeconomic status communit…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312 [Phase 1]
A Phase 1 pharmacokinetic study assessing absorption, metabolism, excretion, and absolute bioavailability of the investigational drug K-312 …
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors [NA]
A completed clinical trial evaluating the effects of Xoçai antioxidant supplements on atherosclerosis risk factors in participants with hype…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Bioequivalence Study of Capsule and Tablet Formulations of TA-8995 [Phase 1]
Completed Phase 1 bioequivalence study comparing capsule and tablet formulations of TA-8995 for dyslipidemia, sponsored by Xention Ltd.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Improving Adherence to Statins Among Minority Populations [NA]
A completed clinical trial evaluated strategies to improve adherence to statin therapy among minority populations.
-
FDA approval · 2016-01-21FDA Approved: GEMFIBROZIL — Supplemental Application (Exelan Pharmaceuticals, Inc.)
The FDA approved a supplemental application for gemfibrozil from Exelan Pharmaceuticals, Inc. (ANDA 077836).
-
CLINICAL_TRIALS other · 2016-01-20Clinical Trial Update: Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. [Phase 1]
Phase 1 study update assessing PK/PD characteristics, safety, and tolerability of a new CKD-519 formulation in healthy male subjects; the tr…
-
CLINICAL_TRIALS research · 2016-01-08Clinical Trial Update: A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204)
This completed study outlines the design of a model cohort for analyzing dyslipidemia and related hypercholesterolemia. The sponsor was Orga…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk [Phase 3]
Phase 3 study in Japanese patients with advanced cardiovascular risk evaluated LDL-C lowering with evolocumab (AMG 145); results were posted…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI) [Phase 1]
Phase 1 study to assess the effect of food on the pharmacokinetics, pharmacodynamics, and safety of CKD-519 FDI in individuals with dyslipid…
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein [Phase 1]
Phase 1 randomized trial evaluated the impact of vinegar on high-density lipoprotein (HDL) cholesterol; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers [Phase 1]
Phase 1 study to evaluate safety, tolerability, and pharmacokinetics of ZYT1 in healthy volunteers; the trial was terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Effect of a Low Fat Milk Product on Lipids Profile in Dyslipidemia Subjects [NA]
This completed trial evaluated the effect of a low-fat milk product on lipid profiles in subjects with primary dyslipidemia. The sponsor was…
-
CLINICAL_TRIALS research · 2015-11-09Clinical Trial Update: Meta-analyses of the Effect of Legumes on Blood Pressure
A update summarizing meta-analyses on whether legume consumption affects blood pressure, suggesting potential reductions in blood pressure w…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects [Phase 2]
Phase 2 trial update reporting efficacy and safety results for PRC-4016 in hypertriglyceridemic subjects. The study has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia [Phase 2]
A Phase 2 trial evaluating PRC-4016 for mixed dyslipidemia was terminated. The update provides status but does not include trial results.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Lipid-lowering Effect of a Plant Stanol Ester Supplement Product [NA]
A completed clinical trial from Raisio Group assessing the lipid-lowering effect of a plant stanol ester supplement (Benecol).
-
FDA approval · 2015-10-15FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: The Effect of a Plant Sterols-Enriched Low-Fat Milk on Lipid Profile in Healthy Southern Chinese (COME-PASS) [Phase 2]
Phase 2 clinical trial update assessing the impact of plant sterols-enriched low-fat milk on lipid profiles in healthy Southern Chinese adul…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039) [Phase 1]
This Phase 1 study evaluates the pharmacokinetics of Anacetrapib (MK0859) in patients with hepatic insufficiency. Results inform potential d…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Safety Study of BMS-823778 in Subjects With Hypercholesterolemia [Phase 2]
This clinical trial update reports the completion of a Phase 2 safety study of BMS-823778 in adults with hypercholesterolemia (dyslipidemia)…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069) [Phase 1]
A Phase 1 study assessing the effect of Niaspan on HDL cholesterol in healthy male subjects has completed.
-
CLINICAL_TRIALS research · 2015-09-23Clinical Trial Update: Meta-analyses of Dietary Pulses and Cardiometabolic Risk
A meta-analysis update examining how dietary pulses relate to cardiometabolic risk factors, summarizing potential effects on lipid, glucose,…
-
FDA approval · 2015-09-16FDA Approved: GEMFIBROZIL — Original Application (NorthStar Rx LLC)
FDA approved an original ANDA for a generic gemfibrozil product manufactured by NorthStar Rx LLC.